Editor’s Note June 5, 2012
This week, we respond to a recent Wall Street Journal article documenting immunotherapy as a new treatment for Cancer. We tell you what companies they […]
OneMedRadio: How Pluristem’s PLX Cells Saved a Dying Child
Pluristem Therapeutics, Inc. (NASDAQCM:PSTI; TASE:PLTR) recently announced that a seven year-old girl suffering from an aplastic bone marrow whose condition was rapidly deteriorating is now experiencing a reversal of her condition.
Boston Scientific to Introduce Two New Devices at the New Cardiovascular Horizons Conference
The Massachusetts based company is a worldwide developer, manufacturer and marketer of medical devices.
Reed Smith partner, Gerry DiFiore Discusses Major Implications of Washington’s JOBS Act
Gerry DiFiore, partnered with the global law firm of Reed Smith is specialized in securities law on emerging growth companies. He recently co-authored a paper on the Jobs Act.
Four Cancer Therapies to Watch
On June 1, more than 25,000 cancer specialists will come together at the 2012 American Society of Clinical Oncology Annual Meeting in Chicago. With ASCO hours away, we look at some small biotech companies making headway in cancer treatment.
Biovest Seeking Marketing Approval in the EU for BiovaxID® Personalized Lymphoma Cancer Vaccine
Biovest has developed a patient-specific, cancer vaccine, BiovaxID®, with three clinical trials completed.
OneMedForum New York 2012 Kick Off Reception Welcomed Over 50 Invited Guests
OneMedPlace kicked off OneMedForum NY 2012 with an exclusive investor networking reception to raise awareness about the upcoming 3rd annual finance conference.
OneMedRadio: NanoViricides CEO Discusses U.S. Patent
NanoViricides, Inc. is a development stage company that is creating special purpose nanomaterials for antiviral therapy.
Synthetic Biologics CEO Jeff Riley Discusses ‘Gene Medicine 2.0’
Synthetic Biologics (SYN) is a biotechnology company focused on the development of synthetic DNA-based therapeutics and innovative disease-modifying medicines for serious illnesses.
Editor’s Note May 22, 2012
This week, OneMedRadio brings you two management interviews. Iconic Data, CEO David LaBorde discusses their lead product SwiftPayMD and why it is changing the face […]